Computational drug repurposing for inflammatory bowel disease using genetic information

As knowledge of the genetics behind inflammatory bowel disease (IBD) has continually improved, there has been a demand for methods that can use this data in a clinically significant way. Genome-wide association analyses for IBD have identified 232 risk genetic loci for the disorder. While identifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Grenier, Liam, Hu, Pingzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352300/
https://www.ncbi.nlm.nih.gov/pubmed/30728920
http://dx.doi.org/10.1016/j.csbj.2019.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352300/
https://www.ncbi.nlm.nih.gov/pubmed/30728920
http://dx.doi.org/10.1016/j.csbj.2019.01.001

Ejemplares similares